BCPC Earnings Date: Feb 19, 2027 (Estimated) — Balchem Corp

NASDAQ · Materials · Specialty Chemicals

Updated Oct 29, 2026

Price $170.40

Market Cap $5.4B

P/E 33.1

52W Range $146.28 – $183.90

Next Earnings Feb 19, 2027 · Before open (est.)

When is BCPC's next earnings date?

Balchem Corp (BCPC) is expected to report Q4 2026 earnings on Friday, February 19, 2027 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.47 on revenue of $287.8M.

How did BCPC do in its last earnings report?

In its most recent report on Oct 23, 2026 (Q3 2026), Balchem Corp posted EPS of $1.57 versus the $1.43 estimate, a beat of 9.8%. Revenue was $290.7M against a $289.2M estimate. The stock's 1-day post-earnings move was +2.2%.

How much does BCPC stock move after earnings?

BCPC beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.8% (up or down) in the day after earnings.

About Balchem Corp

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

🤖 AI Earnings Analysis

Balchem delivered a solid specialty-chemicals quarter, beating EPS estimates by $0.14 as revenue rose 9% year over year to $291 million. Growth is steady, but modest revenue upside makes this a quality beat, not an acceleration story.

AI-generated summary — powered by BigEarnings.

Earnings History

Date	Period	EPS Est.	EPS Act.	Surprise	Revenue	Result	1D Δ	1W Δ	1M Δ
2026-10-23	Q3 2026	1.43	1.57	+9.79%	$290.7M	✅ Beat	+2.18%	-1.63%	—
2026-07-31	Q2 2026	1.42	1.49	+4.93%	$284.0M	✅ Beat	+2.96%	+10.87%	+9.65%
2026-04-30	Q1 2026	1.33	1.33	+0.00%	$270.7M	➖ Inline	-6.76%	-6.89%	-9.58%
2026-02-20	Q4 2025	1.28	1.31	+2.34%	$263.6M	✅ Beat	-2.11%	+3.02%	-7.42%
2025-10-21	Q3 2025	1.33	1.35	+1.50%	$267.6M	✅ Beat	+4.06%	+2.48%	+2.12%
2025-07-31	Q2 2025	1.25	1.27	+1.60%	$255.5M	✅ Beat	+0.25%	+5.20%	+6.51%
2025-04-24	Q1 2025	1.22	1.22	+0.00%	$250.5M	➖ Inline	-2.59%	-1.11%	+5.84%
2025-02-21	Q4 2024	1.11	1.13	+1.80%	$240.0M	✅ Beat	+1.48%	+6.61%	-0.11%